2025 Regular Session • New Hampshire Legislature
SB256
Legislative Summary
Relative to the affordability and safety of clinician administered drugs.
Demographic Impact
Overall analysis of equity impact
80% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/23/2025
Introduced 01/09/2025 and Referred to Health and Human Services; Senate Journal 3
Senate
2/5/2025
Hearing: 02/12/2025, Room 101, Legislative Office Building, 09:15 am; Senate Calendar 9
Senate
2/21/2025
Committee Report: Rereferred to Committee, 03/06/2025; Vote 5-0; Consent Calendar; Senate Calendar 11
Senate
3/6/2025
Rereferred to Committee, Motion Adopted, Voice Vote; 03/06/2025; Senate Journal 6
Senate
Status Information
Current Status
Introduced(1/23/2025)
Chamber
Senate
Committee
Health and Human Services(Senate)
Sponsors
Republican: 5
Primary Sponsor
Tim McGough
Republican